TUNICRIS-julkaisut - Trepo

Viitteet 1-1 / 1

Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group

Kolonen, Aarne; Sinisalo, Marjatta; Huhtala, Heini; Rimpiläinen, Johanna; Rintala, Hannele; Sankelo, Marja; Koivunen, Elli; Silvennoinen, Raija; Räty, Riikka; Ruutu, Tapani; Volin, Liisa; Porkka, Kimmo; Jantunen, Esa; Nousiainen, Tapio; Kuittinen, Taru; Penttilä, Karri; Pyörälä, Marja; Säily, Marjaana; Koistinen, Pirjo; Kauppila, Marjut; Itälä-Remes, Maija; Ollikainen, Hanna; Rauhala, Auvo; Kairisto, Veli; Pelliniemi, Tarja Terttu; Elonen, Erkki (2022)
article

Objectives: AML-2003 study sought to compare the long-term efficacy and safety of IAT and IdAraC-Ida in induction chemotherapy of acute myeloid leukemia (AML) and introduce the results of an integrated genetic and clinical ...